The Methotrexate Access Dilemma
Since the U.S. Supreme Court’s recent decision in the Dobbs v. Jackson Women’s Health Organization case, the Autoimmune Association has heard concerns from patients about their ability to access prescribed methotrexate. The decision, which overturned the 1973 Roe v. Wade ruling protecting the right to abortion under the constitutional right to privacy, has consequences for some people who take methotrexate for autoimmune diseases and for those who prescribe it.
Methotrexate is a medication often prescribed for patients with autoimmune diseases, including psoriasis, inflammatory myositis, vasculitis, rheumatoid arthritis and lupus. Separately, methotrexate, in significantly higher doses than what is prescribed for people with autoimmune diseases, may also be used to terminate a pregnancy. In states where laws banning or severely restricting the termination of pregnancies have already taken effect, some autoimmune patients are reporting difficulty filling their prescriptions for methotrexate. It is important that we understand the extent of and details about these challenges.
If you are having difficulty getting your medication, we would like to hear from you. Please contact us at firstname.lastname@example.org.